The US Food and Drug Administration approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor ...

The director of solid tumor therapy at Stanford Medicine describes how cellular therapies are transforming cancer care.

For nearly 20 years, antidepressants have carried suicide risk warnings for young people. Now, experts are questioning if the ...

In a year of pivotal gastroenterology research, these 10 articles were in a class of their own, according to Dr David Johnson ...

Emerging research revealed how inhaled microplastics may harm respiratory health, with evidence of inflammation, lung lesions ...

The US Food and Drug Administration has issued a final rule that updates the “healthy” nutrient claim on food labels, ...

The Food and Drug Administration (FDA) has added a boxed warning about liver injury to fezolinetant (Veozah), a drug often ...

By 2040, alcohol-associated and metabolic dysfunction–related liver disease will be the leading cause of hepatocellular ...

Oncologists want definitive guidance on whether patients with resectable NSCLC benefit from immunotherapy before and after ...

Moderate and high doses of vitamin D3 daily for 5 years didn’t reduce the risk for type 2 diabetes in healthy older adults ...

A recent study showed that rates of antiretroviral therapy in enrollees living with HIV increased over the years, but women ...

Promising early results from an ongoing randomized, open-label, single-arm, Phase 3 study could pave the way for a Pfizer ...